Cargando…

Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer

PURPOSE: Inflammatory indexes, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII) and lymphocyte-to-monocyte ratio (LMR), have been confirmed as prognostic factors in multiple manigances. However, the prognostic value of these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jingru, Deng, Mingliang, Bi, Minghong, Wang, Yaping, Qiao, Xuxu, Zhang, Shanshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136631/ https://www.ncbi.nlm.nih.gov/pubmed/35662746 http://dx.doi.org/10.2144/fsoa-2021-0162

Ejemplares similares

Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma
por: Bi, Minghong, et al.
Publicado: (2019)

Prognostic value of prognostic nutritional index and its variations in advanced non‐small‐cell lung cancer patients treated with anlotinib monotherapy
por: Chen, Tian, et al.
Publicado: (2022)

The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy
por: Pan, Yuting, et al.
Publicado: (2023)

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan
por: Cuppini, Lucia, et al.
Publicado: (2013)

Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy
por: Fang, Qiyu, et al.
Publicado: (2022)

Prognostic significance of AMPK activation in advanced stage colorectal cancer treated with chemotherapy plus bevacizumab
por: Zulato, E, et al.
Publicado: (2014)

The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure
por: Yuan, Xiao, et al.
Publicado: (2022)

The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients
por: Li, Butuo, et al.
Publicado: (2019)

The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients
por: Shi, Xiaohan, et al.
Publicado: (2022)

The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy
por: Zhang, Lilong, et al.
Publicado: (2023)

Prognostic Value of Immune-Inflammatory Index in PSI IV-V Patients with COVID-19
por: Han, Rui, et al.
Publicado: (2021)

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review
por: Bi, Minghong, et al.
Publicado: (2018)

Laboratory Parameters are Possible Prognostic Markers in Patients with Advanced-stage NSCLC Treated with Bevacizumab plus Chemotherapy
por: Svaton, Martin, et al.
Publicado: (2021)

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]
por: Clarke, Stephen John, et al.
Publicado: (2020)

Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Jiang, Fenge, et al.
Publicado: (2022)

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab
por: Awiwi, Muhammad O, et al.
Publicado: (2022)

Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non‐small cell lung cancer who subsequently underwent immunotherapy
por: Sonehara, Kei, et al.
Publicado: (2021)

Combination of Baseline and Variation of Prognostic Nutritional Index Enhances the Survival Predictive Value of Patients With Advanced Non-Small Cell Lung Cancer Treated With Programmed Cell Death Protein 1 Inhibitor
por: Fang, Qiyu, et al.
Publicado: (2022)

Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
por: Honrubia-Peris, Beatriz, et al.
Publicado: (2021)

Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke
por: Zhou, Yaping, et al.
Publicado: (2022)

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer
por: Passardi, Alessandro, et al.
Publicado: (2016)

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
por: Frontiers Production Office,
Publicado: (2022)

Prognostic Value of the Pretreatment Lung Immune Prognostic Index in Advanced Small Cell Lung Cancer Patients Treated With First-Line PD-1/PD-L1 Inhibitors Plus Chemotherapy
por: Li, Lingling, et al.
Publicado: (2021)

Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
por: Xia, Handai, et al.
Publicado: (2023)

Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients
por: Boros, Angela, et al.
Publicado: (2017)

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy
por: Schuster, Cornelia, et al.
Publicado: (2018)

The prognostic value of the NECPAL instrument, Palliative Prognostic Index, and PROFUND index in elderly residents of nursing homes with advanced chronic condition
por: Esteban-Burgos, Ana Alejandra, et al.
Publicado: (2023)

The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma
por: Qi, Can, et al.
Publicado: (2022)

Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score
por: Pan, Yuting, et al.
Publicado: (2022)

Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC
por: Li, Butuo, et al.
Publicado: (2018)

Prognostic value of absolute lymphocyte count in patients with advanced esophageal cancer treated with immunotherapy: a retrospective analysis
por: Zhao, Qi, et al.
Publicado: (2022)

Prognostic Value of Preoperative Systemic Inflammatory Parameters in Advanced Gastric Cancer
por: Kim, Sung Gon, et al.
Publicado: (2022)

Prognostic values of the prognostic nutritional index, geriatric nutritional risk index, and systemic inflammatory indexes in patients with stage IIB–III cervical cancer receiving radiotherapy
por: Wang, Hong-Bing, et al.
Publicado: (2023)

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study
por: Zhao, Zhiting, et al.
Publicado: (2023)

Prognostic value of the combined preoperative plasma fibrinogen and systemic inflammatory indexes in ESCC patients
por: Cao, Honggang, et al.
Publicado: (2023)

Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
por: Park, Eun Young, et al.
Publicado: (2019)

Cervicomedullary hemangioblastoma treated with bevacizumab
por: Mak, Gloria, et al.
Publicado: (2020)

Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.
por: Allal, A. S., et al.
Publicado: (1998)

Prognostic value of H‐index in patients surgically treated for squamous cell carcinoma of the larynx
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2021)

Machine Learning and BMI Improve the Prognostic Value of GAP Index in Treated IPF Patients
por: Lacedonia, Donato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j62rrgo843chfg71tapg5sea1v